Cutaneous surgery, particularly for skin cancer removal and subsequent reconstruction, demands a careful equilibrium between minimising thromboembolic risk and managing perioperative haemorrhage.
Over the past 40 years, major changes have occurred in the area of anticoagulation management. New strategies have been developed for older anticoagulants, older beliefs have been challenged, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback